28Jan 2021
CDK1/2/5 blockade: killing two birds with one stone

CDK1/2/5 blockade: killing two birds with one stone

Pancreatic ductal adenocarcinoma (PDAC) is an immune resistant tumor. We recently demonstrated that inhibiting CDK1/2/5 by dinaciclib not only blocks immune checkpoint expression, but also triggers histone-dependent immunogenic cell death.

  • #oncology

Like

Save

Share